US 11236065
Pyridazinone compounds and uses thereof
granted A61KA61K31/4525A61K31/501
Quick answer
US patent 11236065 (Pyridazinone compounds and uses thereof) held by EDGEWISE THERAPEUTICS, INC. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- EDGEWISE THERAPEUTICS, INC.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/4525, A61K31/501, A61K31/573, A61K45/06